MANAGEMENT OF ENDOCRINE DISEASE: Adrenocortical carcinoma: differentiating the good from the poor prognosis tumors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MANAGEMENT OF ENDOCRINE DISEASE: Adrenocortical carcinoma: differentiating the good from the poor prognosis tumors
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 178, Issue 5, Pages R215-R230
Publisher
Bioscientifica
Online
2018-02-24
DOI
10.1530/eje-18-0027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma
- (2017) Simon Garinet et al. ENDOCRINE-RELATED CANCER
- Validation of the prognostic role of the "Helsinki Score” in 225 cases of adrenocortical carcinoma
- (2017) Eleonora Duregon et al. HUMAN PATHOLOGY
- Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma
- (2017) Silviu Sbiera et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case Series
- (2017) Sara G Creemers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing
- (2017) Simon Garinet et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Dosage-dependent regulation ofVAV2expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion
- (2017) Carmen Ruggiero et al. Science Signaling
- New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
- (2017) Francesca Salvianti et al. Oncotarget
- Dosage-dependent regulation ofVAV2expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion
- (2017) Carmen Ruggiero et al. Science Signaling
- Outcomes after resection of cortisol-secreting adrenocortical carcinoma
- (2016) Georgios Antonios Margonis et al. AMERICAN JOURNAL OF SURGERY
- An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma
- (2016) Thomas G. Papathomas et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
- (2016) Siyuan Zheng et al. CANCER CELL
- EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression
- (2016) Coralie Drelon et al. HUMAN MOLECULAR GENETICS
- Actual 10-year survivors following resection of adrenocortical carcinoma
- (2016) Thuy B. Tran et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma
- (2016) Yun Mi Choi et al. MEDICINE
- Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy
- (2016) Nada El Ghorayeb et al. MEDICINE
- Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
- (2016) Michael J. Overman et al. Oncotarget
- Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
- (2015) R. Libé et al. ANNALS OF ONCOLOGY
- Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes
- (2015) Georgios Antonios Margonis et al. ANNALS OF SURGICAL ONCOLOGY
- Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence
- (2015) A. R. Glover et al. ENDOCRINE-RELATED CANCER
- Helsinki score—a novel model for prediction of metastases in adrenocortical carcinomas
- (2015) Mirkka Pennanen et al. HUMAN PATHOLOGY
- Whole-Exome Sequencing Characterizes the Landscape of Somatic Mutations and Copy Number Alterations in Adrenocortical Carcinoma
- (2015) C. Christofer Juhlin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
- (2015) Felix Beuschlein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunohistochemical Validation of Overexpressed Genes Identified by Global Expression Microarrays in Adrenocortical Carcinoma Reveals Potential Predictive and Prognostic Biomarkers
- (2015) J. C. Y. Ip et al. ONCOLOGIST
- Genomic landscape of paediatric adrenocortical tumours
- (2015) Emilia M. Pinto et al. Nature Communications
- Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma
- (2015) Gabriela Resende Vieira de Sousa et al. Oncotarget
- Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
- (2015) Céline Pinheiro et al. Oncotarget
- microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
- (2015) Anthony R Glover et al. Oncotarget
- Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System
- (2015) Meora Feinmesser et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer
- (2014) André M. Faria et al. CLINICAL ENDOCRINOLOGY
- Adrenocortical Carcinoma
- (2014) Tobias Else et al. ENDOCRINE REVIEWS
- MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations
- (2014) Eleonora Duregon et al. HUMAN PATHOLOGY
- Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma
- (2014) Eleonora Duregon et al. MODERN PATHOLOGY
- Integrated genomic characterization of adrenocortical carcinoma
- (2014) Guillaume Assié et al. NATURE GENETICS
- The rise of regulatory RNA
- (2014) Kevin V. Morris et al. NATURE REVIEWS GENETICS
- A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease
- (2014) Elliot A. Asare et al. SURGERY
- Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
- (2013) Stefano Caramuta et al. ENDOCRINE-RELATED CANCER
- Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
- (2013) O Chabre et al. ENDOCRINE-RELATED CANCER
- Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993
- (2013) Thomas M.A. Kerkhofs et al. EUROPEAN JOURNAL OF CANCER
- Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
- (2013) Montserrat Ayala-Ramirez et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
- (2013) Alfredo Berruti et al. EUROPEAN UROLOGY
- Molecular Screening for a Personalized Treatment Approach in Advanced Adrenocortical Cancer
- (2013) Maria Cristina De Martino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma
- (2013) Tobias Else et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Analysis of circulating microRNAs in adrenocortical tumors
- (2013) Diana Rita Szabó et al. LABORATORY INVESTIGATION
- Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?
- (2013) Cristina L. Ronchi et al. PLoS One
- PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target
- (2013) Michael J. Demeure et al. SURGERY
- MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
- (2013) Dhaval Patel et al. SURGERY
- Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin
- (2012) Joanne H. Heaton et al. AMERICAN JOURNAL OF PATHOLOGY
- Adrenocortical Tumors
- (2012) Frédérique Tissier et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) A. Berruti et al. ANNALS OF ONCOLOGY
- Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors
- (2012) Annabelle L. Fonseca et al. GENES CHROMOSOMES & CANCER
- DNA Methylation Profiling Identifies Global Methylation Differences and Markers of Adrenocortical Tumors
- (2012) Nesrin S. Rechache et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas
- (2012) Olivia Barreau et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma
- (2012) Mouhammed Amir Habra et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
- (2011) Deniz M Özata et al. ENDOCRINE-RELATED CANCER
- Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients
- (2011) Maria Candida B V Fragoso et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinical and Pathophysiological Implications of Chromosomal Alterations in Adrenocortical Tumors: An Integrated Genomic Approach
- (2011) Olivia Barreau et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours
- (2011) K. J. Schmitz et al. JOURNAL OF CLINICAL PATHOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Clinical impact of TP53 alterations in adrenocortical carcinomas
- (2011) Jens Waldmann et al. LANGENBECKS ARCHIVES OF SURGERY
- The Emergence of lncRNAs in Cancer Biology
- (2011) J. R. Prensner et al. Cancer Discovery
- Antineoplastic Effects of Decitabine, an Inhibitor of DNA Promoter Methylation, in Adrenocortical Carcinoma Cells
- (2010) Insoo Suh ARCHIVES OF SURGERY
- MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy
- (2010) Erin E. Patterson et al. CANCER
- Transcriptome Analysis Reveals that p53 and -Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
- (2010) B. Ragazzon et al. CANCER RESEARCH
- -Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
- (2010) S. Gaujoux et al. CLINICAL CANCER RESEARCH
- The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation
- (2010) Giovanni Lughezzani et al. EUROPEAN JOURNAL OF CANCER
- High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors
- (2010) Silviu Sbiera et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers
- (2010) Martin Fassnacht et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade
- (2010) Barbra S. Miller et al. LANGENBECKS ARCHIVES OF SURGERY
- External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma
- (2009) Laurent Zini et al. BJU INTERNATIONAL
- miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
- (2009) P. S. H. Soon et al. CLINICAL CANCER RESEARCH
- Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
- (2009) T. J. Giordano et al. CLINICAL CANCER RESEARCH
- Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma
- (2009) Wiebke Fenske et al. ENDOCRINE-RELATED CANCER
- Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis
- (2009) Zsófia Tömböl et al. ENDOCRINE-RELATED CANCER
- Transcriptional profiling enables molecular classification of adrenocortical tumours
- (2009) Cecilia Laurell et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification
- (2009) Marco Volante et al. HISTOPATHOLOGY
- Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
- (2009) Aurélien de Reyniès et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival
- (2008) J Waldmann et al. BRITISH JOURNAL OF CANCER
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma
- (2008) Martin Fassnacht et al. CANCER
- Adrenocortical carcinoma in the United States
- (2008) Karl Y. Bilimoria et al. CANCER
- Immunohistochemistry of a Proliferation Marker Ki67/MIB1 in Adrenocortical Carcinomas: Ki67/MIB1 Labeling Index Is a Predictor for Recurrence of Adrenocortical Carcinomas
- (2008) Ryo MORIMOTO et al. ENDOCRINE JOURNAL
- Adrenocortical carcinoma survival rates correlated to genomic copy number variants
- (2008) E. A. Stephan et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started